NASDAQ: ORGNOrigin Materials Inc Stock
$0.65+0.05 (+8.33%)
Updated Apr 21, 2025
ORGN Price
$0.65
Fair Value Price
$0.00
Market Cap
$96.33M
52 Week Low
$0.42
52 Week High
$1.90
P/E
-1.11x
P/B
0.28x
P/S
5.86x
PEG
N/A
Dividend Yield
N/A
Revenue
$31.28M
Earnings
-$83.70M
Gross Margin
1.3%
Operating Margin
-264.23%
Profit Margin
-267.6%
Debt to Equity
0.12
Operating Cash Flow
-$51M
Beta
1.2
Next Earnings
May 2, 2025
Ex-Dividend
N/A
Next Dividend
N/A
ORGN Overview
Origin Materials, Inc. offers a platform which turns the carbon found in non-food biomass into useful materials. Its product replaces petroleum-based materials with decarbonized materials in food and beverage packaging, clothing, textiles, plastics, car parts, carpeting, tires, adhesives, and more. Origin Materials was founded in 2008 and is headquartered in Sacramento, CA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ORGN's potential to beat the market
FStrong Sell
- Stocks with a Zen Rating of Strong Sell (F) had an average loss of -8.02% per year. Learn More
Zen Rating Component Grades
D
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important ORGN news, forecast changes, insider trades & much more!
ORGN News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ORGN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ORGN ($0.65) is overvalued by 484,952.15% relative to our estimate of its Fair Value price of $0.00 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
ORGN ($0.65) is not significantly undervalued (484,952.15%) relative to our estimate of its Fair Value price of $0.00 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ORGN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ORGN due diligence checks available for Premium users.
Valuation
ORGN fair value
Fair Value of ORGN stock based on Discounted Cash Flow (DCF)
Price
$0.65
Fair Value
$0.00
Overvalued by
488,712.24%
ORGN ($0.65) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ORGN ($0.65) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ORGN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
ORGN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-1.11x
Industry
9.89x
Market
27.14x
ORGN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.28x
Industry
1.01x
ORGN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ORGN's financial health
Profit margin
Revenue
$9.2M
Net Income
-$13.5M
Profit Margin
-146.6%
ORGN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ORGN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$378.0M
Liabilities
$39.7M
Debt to equity
0.12
ORGN's short-term assets ($139.17M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ORGN's short-term assets ($139.17M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ORGN's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ORGN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$5.7M
Investing
$9.1M
Financing
$7.0k
ORGN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
ORGN vs Chemical Stocks
Origin Materials Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.